The National Academy of Sciences, Engineering, and Medicine will convene an ad hoc committee to develop a blueprint, including specific, actionable steps for building and sustaining an infrastructure ...

After losing Roche as a partner, Blueprint Medicines has sold US commercial rights to RET inhibitor Gavreto to Rigel Pharma in a deal worth up to $117.5 million.

To associate your repository with the automation-blueprints topic, visit your repo's landing page and select "manage topics." Learn more Footer ...